These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Behavioural pharmacology of the new generation of antipsychotic agents. Moore NA Br J Psychiatry Suppl; 1999; (38):5-11. PubMed ID: 10884895 [TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with first or second generation antipsychotics in rodents: effects on high affinity nicotinic and muscarinic acetylcholine receptors in the brain. Terry AV; Gearhart DA; Mahadik SP; Warsi S; Waller JL Neuroscience; 2006 Jul; 140(4):1277-87. PubMed ID: 16626873 [TBL] [Abstract][Full Text] [Related]
9. Cholinergic aspects of schizophrenia. Tandon R Br J Psychiatry Suppl; 1999; (37):7-11. PubMed ID: 10211133 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo. Ney P; Pandita RK; Newgreen DT; Breidenbach A; Stöhr T; Andersson KE BJU Int; 2008 Apr; 101(8):1036-42. PubMed ID: 18279452 [TBL] [Abstract][Full Text] [Related]
11. Muscarinic m4 receptor activation by some atypical antipsychotic drugs. Zeng XP; Le F; Richelson E Eur J Pharmacol; 1997 Mar; 321(3):349-54. PubMed ID: 9085047 [TBL] [Abstract][Full Text] [Related]
12. Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents. Bymaster FP; Felder CC Mol Psychiatry; 2002; 7 Suppl 1():S57-63. PubMed ID: 11986996 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug. Bymaster FP; Rasmussen K; Calligaro DO; Nelson DL; DeLapp NW; Wong DT; Moore NA J Clin Psychiatry; 1997; 58 Suppl 10():28-36. PubMed ID: 9265914 [TBL] [Abstract][Full Text] [Related]
14. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. Bolden C; Cusack B; Richelson E J Pharmacol Exp Ther; 1992 Feb; 260(2):576-80. PubMed ID: 1346637 [TBL] [Abstract][Full Text] [Related]
15. The procholinergic effects of the atypical antipsychotic olanzapine are independent of muscarinic autoreceptor inhibition. Tzavara ET; Bymaster FP; Nomikos GG Mol Psychiatry; 2006 Jul; 11(7):619-21. PubMed ID: 16801977 [No Abstract] [Full Text] [Related]
17. Nicotine and clozapine selectively reverse a PCP-induced deficit of PPI in BALB/cByJ but not NMRI mice: comparison with risperidone. Andreasen JT; Andersen KK; Nielsen EØ; Mathiasen L; Mirza NR Behav Brain Res; 2006 Feb; 167(1):118-27. PubMed ID: 16225935 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the in-vivo muscarinic cholinergic receptor availability in patients treated with clozapine and olanzapine. Raedler TJ Int J Neuropsychopharmacol; 2007 Apr; 10(2):275-80. PubMed ID: 16945161 [TBL] [Abstract][Full Text] [Related]
20. The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions? Davies MA; Compton-Toth BA; Hufeisen SJ; Meltzer HY; Roth BL Psychopharmacology (Berl); 2005 Apr; 178(4):451-60. PubMed ID: 15765260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]